In the present study, we firstly investigated the RASSF1A A133S polymorphism and the risk to ESCC and GCA development on the patients from Linzhou, the high incidence area for both ESCC and GCA. The gene discussed is RASSF1; the disease is esophageal squamous cell carcinoma.